Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2549

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Anemia
Cancer
Lung Cancer

Interventions

DRUG: Darbepoetin alfa
DRUG: Placebo

Sponsor

Amgen